Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 21, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description This Amendment No. 1 to the Annual Report on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K for the year ended December 31, 2022 (the “Original Report”) of Abeona Therapeutics Inc. (the “Company”), which was filed with the Securities and Exchange Commission (“SEC”) on March 29, 2023. This Amendment is being filed solely to amend the signature page to remove the conformed signature of one of the Company’s directors, which was inadvertently included in the Original Report. In addition, the Company has updated the address    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-15771    
Entity Registrant Name ABEONA THERAPEUTICS INC.    
Entity Central Index Key 0000318306    
Entity Tax Identification Number 83-0221517    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 6555 Carnegie Ave    
Entity Address, Address Line Two 4th Floor    
Entity Address, City or Town Cleveland    
Entity Address, State or Province OH    
Entity Address, Postal Zip Code 44103    
City Area Code (646)    
Local Phone Number 813-4701    
Title of 12(b) Security Common Stock, $0.01 par value    
Trading Symbol ABEO    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 28,754,000
Entity Common Stock, Shares Outstanding   17,708,968  
Documents Incorporated by Reference [Text Block] Portions of the Definitive Proxy Statement for the registrant’s 2023 Annual Meeting of Stockholders to be held May 17, 2023, are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K.    
ICFR Auditor Attestation Flag false    
Auditor Name WHITLEY PENN LLP    
Auditor Location Plano, Texas    
Auditor Firm ID 726